Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acrux Ltd.

www.acrux.com.au

Latest From Acrux Ltd.

A New Dawn For Female Sex Dysfunction Drugs? FDA Meeting Cheers Sponsors

Experts convened by FDA to discuss female sexual dysfunction disorders, including problems with desire and arousal, settle on endpoints contrary to new DSM, but are in line with trials of Sprout’s flibanserin, the leading drug in development.

BioPharmaceutical Clinical Trials

Australia Earnings Roundup: CSL, Acrux, Pharmaxis, Mesoblast (Part 1)

PharmAsia News combs through earnings reports to bring you highlights on Australian biotech firms. We start with CSL Ltd, Acrux, Pharmaxis and Mesoblast for the period ended Dec. 31, 2012.

BioPharmaceutical Australia

Hunter to merge with Probiomics as it seeks partner for Phase II COPD vaccine

Public unlisted Australian drug development company Hunter Immunology is recommending that its shareholders accept the takeover offer from listed biotech firm Probiomics.

Infectious Diseases Respiratory

Aussie gene patenting debate heats up

An Australian private member's bill which proposes a ban on the patenting of human genes and biological materials will have ramifications not just for the local R&D industries. It could change the way the country is viewed as a place for inward investment.

Cancer Australia
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Acrux Ltd.
  • Senior Management
  • Richard Treagus, CEO
    Jon Pilcher, CFO
    Nina Wilkins, PhD, Dir., Bus. Dev.
    Adam Watkinson, PhD, CSO
  • Contact Info
  • Acrux Ltd.
    Phone: (61) 3 8379 0100
    103-113 Stanley St.
    West Melbourne, VIC 3003
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register